<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://dermfield.com/articles/elle-rounds-up-dermatologist-picked-otc-dark-spot-treatments-56ead2e7</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T18:05:01.128Z</news:publication_date>
      <news:title>ELLE Rounds Up Dermatologist-Picked OTC Dark Spot Treatments</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/incyte-names-first-ever-ingenuity-awards-winners-in-hidradenitis-suppurativa-48eb229c</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T17:05:01.073Z</news:publication_date>
      <news:title>Incyte Names First-Ever Ingenuity Awards Winners in Hidradenitis Suppurativa</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/eczema-drug-restored-all-19-dystrophic-nails-in-a-boy-case-report-shows-295cd2fe</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T17:05:01.073Z</news:publication_date>
      <news:title>Eczema Drug Restored All 19 Dystrophic Nails in a Boy, Case Report Shows</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/roflumilast-cream-0-05-draws-attention-for-infant-atopic-dermatitis-14dd101d</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T17:05:01.073Z</news:publication_date>
      <news:title>Roflumilast Cream 0.05% Draws Attention for Infant Atopic Dermatitis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/dupilumab-tied-to-lower-atopic-march-risk-in-kids-with-eczema-f4a4f1ac</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T16:35:01.044Z</news:publication_date>
      <news:title>Dupilumab Tied to Lower Atopic March Risk in Kids With Eczema</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/don-t-miss-stasis-dermatitis-in-your-diagnosis-7d8dab66</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T16:35:01.044Z</news:publication_date>
      <news:title>Don&apos;t Miss Stasis Dermatitis in Your Diagnosis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/real-world-persistence-data-emerge-for-il-23-biologics-in-plaque-psoriasis-078bb904</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T16:05:01.007Z</news:publication_date>
      <news:title>Real-World Persistence Data Emerge for IL-23 Biologics in Plaque Psoriasis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/upadacitinib-shows-response-in-treatment-experienced-atopic-dermatitis-cases-df100e48</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T15:05:00.932Z</news:publication_date>
      <news:title>Upadacitinib Shows Response in Treatment-Experienced Atopic Dermatitis Cases</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/allergy-pill-studied-as-shield-against-chemo-skin-damage-ef24864b</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T15:05:00.932Z</news:publication_date>
      <news:title>Allergy Pill Studied as Shield Against Chemo Skin Damage</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/2026-dermatology-update-what-approvals-and-pipelines-signal-3b555a63</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T15:05:00.932Z</news:publication_date>
      <news:title>2026 Dermatology Update: What Approvals and Pipelines Signal</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/moderna-s-october-melanoma-readout-precedes-a-november-decision-2acada4c</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T14:00:00.871Z</news:publication_date>
      <news:title>Moderna&apos;s October Melanoma Readout Precedes a November Decision</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/bitopertin-hits-all-end-points-in-phase-3-apollo-trial-for-epp-d3a351a3</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T14:00:00.871Z</news:publication_date>
      <news:title>Bitopertin Hits All End Points in Phase 3 APOLLO Trial for EPP</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/fangzhou-and-cutia-therapeutics-team-up-on-ai-dermatology-5196ae55</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T13:30:00.852Z</news:publication_date>
      <news:title>Fangzhou and Cutia Therapeutics Team Up on AI Dermatology</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/faers-analysis-flags-psychiatric-events-on-lebrikizumab-fe6ee483</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T13:00:00.833Z</news:publication_date>
      <news:title>FAERS Analysis Flags Psychiatric Events on Lebrikizumab</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/real-world-persistence-data-emerge-for-il-23-biologics-in-plaque-psoriasis-f86e0d32</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T12:30:03.354Z</news:publication_date>
      <news:title>Real-World Persistence Data Emerge for IL-23 Biologics in Plaque Psoriasis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/dosing-frequency-shapes-adherence-in-older-psoriasis-patients-8ad1a206</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T12:30:03.354Z</news:publication_date>
      <news:title>Dosing Frequency Shapes Adherence in Older Psoriasis Patients</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/older-psoriasis-patients-face-access-and-dosing-hurdles-52ff636d</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T12:30:03.354Z</news:publication_date>
      <news:title>Older Psoriasis Patients Face Access and Dosing Hurdles</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/glp-1-drugs-show-anti-inflammatory-signal-in-psoriasis-and-obesity-77062480</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T12:30:03.354Z</news:publication_date>
      <news:title>GLP-1 Drugs Show Anti-Inflammatory Signal in Psoriasis and Obesity</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/skin-commensal-bacillus-reprograms-volatiles-to-repel-mosquitoes-d2329ca0</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T09:55:00.703Z</news:publication_date>
      <news:title>Skin Commensal Bacillus Reprograms Volatiles to Repel Mosquitoes</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/oily-skin-may-increase-dermal-exposure-to-air-pollutants-6a90f711</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T08:25:00.639Z</news:publication_date>
      <news:title>Oily Skin May Increase Dermal Exposure to Air Pollutants</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/ai-recommends-fillers-it-has-never-touched-a-face-to-place-dac1a56e</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T07:55:00.605Z</news:publication_date>
      <news:title>AI Recommends Fillers It Has Never Touched a Face to Place</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/evaxion-posts-three-year-data-for-personalized-melanoma-vaccine-evx-01-547c8483</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T07:55:00.605Z</news:publication_date>
      <news:title>Evaxion Posts Three-Year Data for Personalized Melanoma Vaccine EVX-01</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/final-melanoma-survival-data-headed-to-esmo-faron-confirms-21307ab3</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T07:55:00.605Z</news:publication_date>
      <news:title>Final Melanoma Survival Data Headed to ESMO, Faron Confirms</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/evaxion-reports-three-year-data-for-melanoma-vaccine-evx-01-911bbe93</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T07:40:00.595Z</news:publication_date>
      <news:title>Evaxion Reports Three-Year Data for Melanoma Vaccine EVX-01</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/evaxion-brings-three-year-evx-01-melanoma-data-to-esmo-2026-979ccbc3</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T07:40:00.595Z</news:publication_date>
      <news:title>Evaxion Brings Three-Year EVX-01 Melanoma Data to ESMO 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/moderna-and-merck-present-phase-3-melanoma-data-on-personalized-cancer-vaccine-2d34ac53</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T05:55:00.480Z</news:publication_date>
      <news:title>Moderna and Merck Present Phase 3 Melanoma Data on Personalized Cancer Vaccine</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/cosmetic-dermatology-enters-the-longevity-science-conversation-011b2794</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T05:50:00.476Z</news:publication_date>
      <news:title>Cosmetic Dermatology Enters the Longevity Science Conversation</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/could-skin-reveal-new-clues-about-aging-and-frailty-958ddd8c</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T02:50:00.283Z</news:publication_date>
      <news:title>Could Skin Reveal New Clues About Aging and Frailty?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/hugel-builds-direct-us-sales-force-for-letybo-launches-k-tox-push-edb6ea60</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T00:50:00.152Z</news:publication_date>
      <news:title>Hugel Builds Direct US Sales Force for Letybo, Launches K-TOX Push</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/invion-reports-79-disease-control-in-phase-1-skin-cancer-trial-f5d65f3a</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T00:20:00.125Z</news:publication_date>
      <news:title>Invion Reports 79% Disease Control in Phase 1 Skin Cancer Trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/ashland-croda-and-innospec-shortlisted-for-laura-marshall-awards-7c4df794</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T00:10:00.117Z</news:publication_date>
      <news:title>Ashland, Croda and Innospec shortlisted for Laura Marshall awards</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/aafp-publishes-melanoma-diagnosis-and-treatment-guidance-4e84a078</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T20:47:37.673Z</news:publication_date>
      <news:title>AAFP Publishes Melanoma Diagnosis and Treatment Guidance</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/nemolizumab-in-children-under-12-the-open-eczema-question-fa122d8e</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T19:12:37.595Z</news:publication_date>
      <news:title>Nemolizumab in Children Under 12: The Open Eczema Question</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/integrative-medicine-is-making-its-way-into-aesthetic-dermatology-c87a757d</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T14:42:37.249Z</news:publication_date>
      <news:title>Integrative Medicine Is Making Its Way Into Aesthetic Dermatology</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/lilly-eyes-aesthetic-medicine-as-glp-1-weight-loss-reshapes-faces-f55ea70f</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T13:37:37.201Z</news:publication_date>
      <news:title>Lilly Eyes Aesthetic Medicine as GLP-1 Weight Loss Reshapes Faces</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/reflectance-confocal-microscopy-caught-melanomas-earlier-retrospective-study-fin-b6a5c507</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T13:37:37.201Z</news:publication_date>
      <news:title>Reflectance Confocal Microscopy Caught Melanomas Earlier, Retrospective Study Finds</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/nebraska-clinics-offer-new-therapy-for-ocular-melanoma-liver-spread-32a9d971</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T13:07:37.181Z</news:publication_date>
      <news:title>Nebraska Clinics Offer New Therapy for Ocular Melanoma Liver Spread</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/bemotrizinol-s-approval-prompts-five-questions-patients-will-ask-1d4da0c4</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T11:37:37.096Z</news:publication_date>
      <news:title>Bemotrizinol&apos;s Approval Prompts Five Questions Patients Will Ask</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/male-and-female-skin-play-by-different-rules-scientists-find-84ad788d</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T11:07:37.082Z</news:publication_date>
      <news:title>Male and Female Skin Play by Different Rules, Scientists Find</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-study-sequential-1550-nm-fractional-laser-meets-pdl-for-port-wine-birthmark-8a199d16</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T11:02:37.071Z</news:publication_date>
      <news:title>JAAD Study: Sequential 1550-nm Fractional Laser Meets PDL for Port-Wine Birthmarks</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/week-4-on-abrocitinib-predicts-week-12-remission-in-atopic-dermatitis-d41d2688</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T11:02:37.071Z</news:publication_date>
      <news:title>Week 4 on Abrocitinib Predicts Week 12 Remission in Atopic Dermatitis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/second-opinion-pathology-reviews-before-derm-surgery-a-jaad-look-16b6b765</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T11:02:37.071Z</news:publication_date>
      <news:title>Second-Opinion Pathology Reviews Before Derm Surgery: A JAAD Look</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/litifilimab-hits-24-week-endpoint-bar-in-amethyst-phase-2-cutaneous-lupus-trial-3f6f1e81</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T11:02:37.071Z</news:publication_date>
      <news:title>Litifilimab Hits 24-Week Endpoint Bar in AMETHYST Phase 2 Cutaneous Lupus Trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jaad-examines-lymphoma-risk-signals-in-hidradenitis-suppurativa-23865fa4</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T11:02:37.071Z</news:publication_date>
      <news:title>JAAD Examines Lymphoma Risk Signals in Hidradenitis Suppurativa</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/atopic-dermatitis-is-systemic-and-doing-nothing-has-a-cost-62741a7d</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T08:02:36.841Z</news:publication_date>
      <news:title>Atopic Dermatitis Is Systemic, and &apos;Doing Nothing&apos; Has a Cost</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/that-winter-itch-may-not-be-dry-skin-it-could-be-eczema-cb37afe6</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T07:32:36.812Z</news:publication_date>
      <news:title>That Winter Itch May Not Be Dry Skin — It Could Be Eczema</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/psoriasis-care-shifts-focus-beyond-skin-clearance-alone-c728a4be</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T07:32:36.812Z</news:publication_date>
      <news:title>Psoriasis Care Shifts Focus Beyond Skin Clearance Alone</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/galderma-buys-zo-skin-health-for-1-5-billion-f90bc41e</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T07:02:36.778Z</news:publication_date>
      <news:title>Galderma Buys ZO Skin Health for $1.5 Billion</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/dermatologists-warn-gen-z-s-multi-active-routines-may-backfire-8c2779b4</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T07:02:36.778Z</news:publication_date>
      <news:title>Dermatologists warn Gen Z&apos;s multi-active routines may backfire</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/luis-garza-m-d-ph-d-on-what-hidradenitis-suppurativa-is-not-d8d38531</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T07:02:36.778Z</news:publication_date>
      <news:title>Luis Garza, M.D., Ph.D., on What Hidradenitis Suppurativa Is Not</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/dermatologist-debunks-viral-black-sesame-milk-glowing-skin-trend-a9705a86</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T07:02:36.778Z</news:publication_date>
      <news:title>Dermatologist Debunks Viral Black Sesame Milk &apos;Glowing Skin&apos; Trend</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/in-utah-a-4-99-ai-acne-app-can-now-issue-prescriptions-9ef0a9d9</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T07:02:36.778Z</news:publication_date>
      <news:title>In Utah, a $4.99 AI Acne App Can Now Issue Prescriptions</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/stanford-medicine-weighs-in-on-red-light-therapy-evidence-bbbd3608</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T07:02:36.778Z</news:publication_date>
      <news:title>Stanford Medicine Weighs In on Red Light Therapy Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/indian-dermatology-online-journal-publishes-comprehensive-abrocitinib-review-b217fdc3</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T06:02:36.683Z</news:publication_date>
      <news:title>Indian Dermatology Online Journal Publishes Comprehensive Abrocitinib Review</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/proya-opens-european-innovation-lab-in-paris-anchored-on-skin-longevity-99728b3a</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T05:37:36.660Z</news:publication_date>
      <news:title>Proya Opens European Innovation Lab in Paris, Anchored on Skin Longevity</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/dermatology-times-publishes-conferences-calendar-for-april-2026-6f920f21</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T05:32:36.651Z</news:publication_date>
      <news:title>Dermatology Times Publishes Conferences Calendar for April 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/six-dermatologists-named-ilds-2027-young-achiever-award-winners-3a7ac14b</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T05:02:36.618Z</news:publication_date>
      <news:title>Six Dermatologists Named ILDS 2027 Young Achiever Award Winners</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/topical-febuxostat-quiets-psoriasis-in-mouse-model-bioengineer-reports-6eb0b598</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-17T23:27:36.248Z</news:publication_date>
      <news:title>Topical Febuxostat Quiets Psoriasis in Mouse Model, Bioengineer Reports</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/oridonin-ointment-reduces-psoriasis-like-inflammation-in-mouse-model-653db8f1</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-17T21:52:36.148Z</news:publication_date>
      <news:title>Oridonin Ointment Reduces Psoriasis-Like Inflammation in Mouse Model</news:title>
    </news:news>
  </url>
</urlset>
